Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |